Waksal Harlan 4
4 · Lyra Therapeutics, Inc. · Filed Jun 21, 2022
Insider Transaction Report
Form 4
Waksal Harlan
DirectorExecutive Chair
Transactions
- Award
Stock Option
2022-06-16+953,002→ 953,002 totalExercise: $5.09Exp: 2032-06-15→ Common Stock (953,002 underlying)
Footnotes (1)
- [F1]On June 16, 2022, the Reporting Person was granted an option to purchase 953,002 shares of common stock. The option vests and becomes exercisable as to 317,667 shares underlying the option when the Issuer's market capitalization reaches $250,000,000; (ii) 317,667 shares underlying the option when the Issuer's market capitalization reaches $350,000,000; and (iii) 317,668 shares underlying the option when the Issuer's market capitalization reaches $500,000,000, all subject to the Reporting Person's continued service to the Issuer through each such date.